Colinz Laboratories Share Price Today

Colinz Laboratories Q2FY27 Results: Net profit falls 10% YoY to ₹12.65 lakh

Net profit declined 9.96% YoY to ₹12.65 lakh in Q2FY27. Revenue from operations rose 11.67% YoY to ₹155.00 lakh. H1FY27 net profit surged to ₹252.77 lakh driven by ₹276.33 lakh asset sale gain. Operating cash flow turned negative at ₹131.81 lakh for H1FY27.

Colinz Labs declares non-applicability of related party disclosures

Colinz Laboratories Limited declared non-applicability of Related Party Transaction disclosures for Q2FY27. Company cited exemption under Regulation 15(2)(a) of SEBI (LODR) Regulations, 2015. Compliance with Regulations 17 to 27 and specific clauses of Regulation 46 is not applicable. Filing signed by Director Vijaya Mani on October 1, 2026.

Colinz Labs shareholders approve all resolutions at 40th AGM

All four resolutions at the 40th AGM passed with requisite majority. Promoters voted in favour of all leadership reappointments. Only 6 votes against recorded across all resolutions. No physical attendance; all participation via VC/OAVM.

Colinz Laboratories open offer sees only six shares tendered at ₹54

Only six equity shares were tendered in the open offer for Colinz Laboratories, valuing just ₹324 against a potential ₹3.54 crore. Acquirers Annjana Dugar, Likhitta Dugar, and Antariksh Dugar offered ₹54 per share to buy up to 26% of the voting share capital. The open offer was triggered by a pending Share Purchase Agreement for 8,70,500 shares (34.56%) which remains unconsummated. Public shareholding stands at 34.39% post-offer, subject to downward revision upon reclassification of promoter-held shares.

Colinz Laboratories schedules 40th AGM for September 22, 2026

Colinz Laboratories holds its 40th AGM on September 22, 2026, via video conference. Agenda includes adopting FY26 financials and reappointing CEO N. K. Menon. Vijaya Mani is up for appointment as a Non-Executive, Non-Independent Director. Remote e-voting runs from September 19 to September 21, 2026. Book closure period is from September 15 to September 22, 2026.

Colinz Laboratories open offer opens Aug 7 at ₹54 per share

The open offer for a 26% stake in Colinz Laboratories opened on August 7, 2026, at ₹54 per share. The acquirers aim to acquire up to 6,54,966 shares. The IDC recommended the offer despite the market trading at a premium. The tendering period ends on August 20, 2026.